Helicobacter pylori is a bacterium that colonizes the stomach lining and can cause chronic gastritis, ulcers, and gastric cancer. Regarding longevity, the evidence is conflicting: persistent infection increases the risk of gastric malignancies and nutrient deficiencies (e.g., iron, vitamin B12), potentially shortening lifespan. Conversely, some observational studies suggest a protective role against asthma, esophageal cancer, and inflammatory bowel disease – possibly via immune modulation. The decision to eradicate should be individualized based on symptoms, family history, and risk factors. A DNA longevity test (e.g., MyBody-X DNA Longevity Test) analyzing FOXO3 variants cannot assess Helicobacter status or biological age. Key takeaway: For symptomatic individuals or those with a family history of gastric cancer, medical evaluation and eradication therapy are warranted. For asymptomatic people without risk factors, the benefit of routine treatment is unclear. Evidence is mixed (human-observational, mechanistic).
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-be21fefb3dc1c742656869d3